3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fatigue
6
Brain Neoplasms
3
Sleep Wake Disorders
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Pain
1
Mental Disorders
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Depression
1
Central Nervous System Neoplasms
1
Caregiver Burden
1
Breast Neoplasms
1
Interventions
Temozolomide
53
Bevacizumab
33
Radiotherapy
27
Radiation
12
Erlotinib Hydrochloride
12
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
8
Irinotecan
6
Vorinostat
5
Sorafenib
5
Sirolimus
5
temsirolimus
4
Magnetic Resonance Spectroscopy
4
Immunoglobulin G
4
Disulfides
4
Carmustine
4
veliparib
3
plerixafor
3
carmustine, poliferprosan 20 drug combination
3
Radiosurgery
3
Everolimus
3
Dasatinib
3
Bortezomib
3
vandetanib
2
tandutinib
2
sargramostim
2
poly ICLC
2
pembrolizumab
2
pazopanib
2
ferric pyrophosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gliosarcoma
×
Methylphenidate
×
Clear all
No trials found.